These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 33587124)
1. The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA. Sharfstein JM; Goodman JL; Borio L JAMA; 2021 Mar; 325(12):1153-1154. PubMed ID: 33587124 [No Abstract] [Full Text] [Related]
2. FDA authorizes Johnson & Johnson COVID-19 vaccine. Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088 [No Abstract] [Full Text] [Related]
3. FDA authorizes first single-shot COVID-19 vaccine. Mullard A Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753 [No Abstract] [Full Text] [Related]
4. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19. Kesselheim AS; Darrow JJ; Kulldorff M; Brown BL; Mitra-Majumdar M; Lee CC; Moneer O; Avorn J Health Aff (Millwood); 2021 Jan; 40(1):25-32. PubMed ID: 33211535 [TBL] [Abstract][Full Text] [Related]
5. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health. Zuckerman DM Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730 [No Abstract] [Full Text] [Related]
6. 2021 FDA approvals: value driven by COVID-19 vaccines. Baedeker M; Ringel MS; Schulze U Nat Rev Drug Discov; 2022 Feb; 21(2):90. PubMed ID: 35039671 [No Abstract] [Full Text] [Related]
7. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations. Krause PR; Gruber MF N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383 [No Abstract] [Full Text] [Related]
9. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine. Dal-Ré R Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602 [No Abstract] [Full Text] [Related]
10. FDA authorizes Moderna COVID-19 vaccine. Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345 [No Abstract] [Full Text] [Related]
11. Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency. Avorn J; Kesselheim A JAMA; 2020 Oct; 324(13):1284-1285. PubMed ID: 32870268 [No Abstract] [Full Text] [Related]
12. Emergency Use Authorizations of COVID-19-Related Medical Products. Moshkovits I; Shepshelovich D JAMA Intern Med; 2022 Feb; 182(2):228-229. PubMed ID: 34928303 [TBL] [Abstract][Full Text] [Related]
13. FDA authorizes Pfizer-BioNTech COVID-19 vaccine. Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996 [No Abstract] [Full Text] [Related]
14. Unwavering Regulatory Safeguards for COVID-19 Vaccines. Shah A; Marks PW; Hahn SM JAMA; 2020 Sep; 324(10):931-932. PubMed ID: 32766736 [No Abstract] [Full Text] [Related]
15. Politicians must dial down the rhetoric over COVID vaccines. Nature; 2021 Mar; 591(7851):502. PubMed ID: 33758409 [No Abstract] [Full Text] [Related]
16. COVID-vaccine results are on the way - and scientists' concerns are growing. Mallapaty S; Ledford H Nature; 2020 Oct; 586(7827):16-17. PubMed ID: 32978611 [No Abstract] [Full Text] [Related]
17. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine. Dal-Ré R; Caplan AL; Gluud C; Porcher R Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636 [TBL] [Abstract][Full Text] [Related]